Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec:82:21-22.
doi: 10.1016/j.ejim.2020.10.015. Epub 2020 Oct 16.

Does hydroxychloroquine reduce mortality for COVID-19?

Silvano Gallus  1 , Antonio Clavenna  2 , Alessandra Lugo  3
Affiliations
Comment

Does hydroxychloroquine reduce mortality for COVID-19?

Silvano Gallus et al. Eur J Intern Med. 2020 Dec.
No abstract available

Keywords: Azithromycin; COVID-19; Hydroxychloroquine; Mortality.

PubMed Disclaimer

Conflict of interest statement

Silvano Gallus and Alessandra Lugo are currently collaborating in various projects with some of the Investigators of the CORIST Study, including Licia Iacoviello, Maria Laura Bonaccio, Carlo Signorelli, Anna Odone and Laura Carrozzi. No other competing interests are declared.

Comment on

References

    1. COVID-19 RISK and Treatments (CORIST) Collaboration Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: findings from the observational multicentre Italian CORIST study. Eur J Intern Med. 2020 doi: 10.1016/j.ejim.2020.08.019. - DOI - PMC - PubMed
    1. Bonow R.O., Hernandez A.F., Turakhia M. Hydroxychloroquine, coronavirus disease 2019, and QT prolongation. JAMA Cardiol. 2020;5:986–987. - PubMed
    1. Thomson K., Nachlis H. Emergency use authorizations during the COVID-19 pandemic: lessons from hydroxychloroquine for vaccine authorization and approval. JAMA. 2020;324(13):1282–1283. doi: 10.1001/jama.2020.16253. - DOI - PubMed
    1. Shukla A.M., Wagle Shukla A. Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues. Drugs Context. 2019;8 doi: 10.7573/dic.2019-9-1. 2019-9-1. - DOI - PMC - PubMed
    1. Das R.R., Jaiswal N., Dev N., Jaiswal N., Naik S.S., Sankar J. Efficacy and safety of anti-malarial drugs (chloroquine and hydroxy-chloroquine) in treatment of COVID-19 infection: a systematic review and meta-analysis. Front Med. 2020;7:482. - PMC - PubMed